JIANYANG WANG

Academic / Other · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety	Phase 2	2024-01-01
Completed	The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy	Phase 2	2023-07-20